Novel minicircle vector for gene therapy in murine myocardial infarction

Keyphrases

• Activity Level 33%
• Bioluminescence Imaging 33%
• C2C12 Myoblasts 33%
• Cardiac Contractility 33%
• Cardiac Gene Therapy 33%
• Double Fusion 33%
• Enhanced Green Fluorescent Protein (eGFP) 33%
• Firefly Luciferase 33%
• Functional Benefit 33%
• Gene Expression 66%
• Gene Therapy 100%
• Hypoxia-inducible factor-1α (HIF-1α) 66%
• Minicircle 100%
• Minicircle Vector 100%
• Myocardial Infarction 100%
• Non-invasive Measurement 33%
• Non-viral Vectors 66%
• Plasmid 100%
• Reporter Gene 33%
• Therapeutic Gene 33%
• Therapy Protocols 33%
• Transfection Efficiency 66%
• Transgene Expression 33%
• Viral Vectors 33%

Biochemistry, Genetics and Molecular Biology

• Bioluminescence Imaging 25%
• C2C12 25%
• FVB/N Mouse 25%
• Gene Expression 50%
• Gene Therapy 100%
• Green Fluorescent Protein 25%
• Heart Muscle Contractility 25%
• Hypoxia Inducible Factor 1 50%
• Luciferase 25%
• Minicircle 100%
• Mouse 25%
• Plasmid 75%
• Reporter Gene 25%
• Transfection 50%
• Transgene 25%
• Virus Vector 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Enhanced Green Fluorescent Protein 50%
• Firefly Luciferase 50%
• FVB/N Mouse 50%
• Heart Infarction 100%
• Hypoxia Inducible Factor 1 100%
• Mouse 50%
• Viral Vector 50%